Showing results (801-810 of 1,839) with videos related to

Sort By:
Pageof 184
ESMO Open|December 20, 2023
Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD)L Incorvaia, G Badalamenti, G Novo, et al.
ESMO Open|November 28, 2023
Efficacy of immune checkpoint inhibitors in alveolar soft-part sarcoma: results from a retrospective worldwide registryN Hindi, A Razak, E Rosenbaum, et al.
ESMO Open|February 6, 2024
Rational thresholding of circulating tumor DNA concentration for improved surveillance of metastatic breast cancerG A Martens, J Demol, F Dedeurwaerdere, et al.
ESMO Open|January 9, 2024
Effectiveness of next-generation sequencing for patients with advanced non-small-cell lung cancer: a population-based registry studyD-W Kang, S-K Park, Y L Yu, et al.
ESMO Open|March 16, 2024
Elements of successful patient involvement in clinical cancer trials: a review of the literatureI Shakhnenko, O Husson, D Chuter, et al.
ESMO Open|October 5, 2024
Volumetric measurement to evaluate treatment response to induction chemotherapy on MRI outperformed RECIST guideline in outcome prediction in advanced nasopharyngeal carcinomaT S A Kwong, H S Leung, F K F Mo, et al.
ESMO Open|September 19, 2024
Evaluation of the attributable fraction and burden of HPV-related oropharyngeal cancers in Greece-the ORPHEAS studyA Psyrri, G Psychogios, E Kyrodimos, et al.
ESMO Open|September 17, 2024
Characteristics and clinical outcomes of breast cancer in young BRCA carriers according to tumor histologyE Agostinetto, M Bruzzone, A-S Hamy, et al.
ESMO Open|September 17, 2024
Liquid biopsy in triple-negative breast cancer: unlocking the potential of precision oncologyR Mazzeo, J Sears, L Palmero, et al.
ESMO Open|October 2, 2024
Window of opportunity trials with immune checkpoint inhibitors in triple-negative breast cancerA Quintana, K S Saini, L Vidal, et al.
Pageof 184